Skip to Content

Caliber Imaging & Diagnostics Inc LCDX

Morningstar Rating
$0.00 0.00 (0.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LCDX is trading within a range we consider fairly valued.
Price
$0.00
Fair Value
$3.44
Uncertainty
Extreme
1-Star Price
$1.74
5-Star Price
$8.20
Economic Moat
Zgqwj
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LCDX is a good fit for your portfolio.

Trading Information

Previous Close Price
$0.00
Day Range
$0.000.00
52-Week Range
$0.000.05
Bid/Ask
$0.05 / $0.20
Market Cap
$850.74
Volume/Avg
465 / 1,779

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Caliber Imaging & Diagnostics Inc is a medical device company engaged in developing, manufacturing, marketing & selling point-of-care cellular imaging systems to diagnose skin cancer. It offers clinical imaging and research imaging solutions that shows tissue at the cellular level. Its products portfolio includes; VivaScope; VivaScope 3000, 1500 & 2500; and VivaNet and VivaScan.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Total Number of Employees
28

Valuation

Metric
LCDX
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LCDX
Quick Ratio
0.07
Current Ratio
0.22
Interest Coverage
−9.20
Quick Ratio
No chart available

Profitability

Metric
LCDX
Return on Assets (Normalized)
−191.60%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
Return on Assets
No chart available
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesMxvlpdcPbcbmr$183.8 Bil
SYK
Stryker CorpMnthlvskthHvtc$127.8 Bil
MDT
Medtronic PLCDkskfwkzwWybpfq$105.0 Bil
BSX
Boston Scientific CorpPjwmvzxWptrk$99.9 Bil
EW
Edwards Lifesciences CorpFpkkvtbbRtvlrgy$52.5 Bil
DXCM
DexCom IncXtnmvpjwlsYgdls$51.9 Bil
ZBH
Zimmer Biomet Holdings IncJmyltfnqFhcg$24.9 Bil
ALGN
Align Technology IncXhxcjyczXgknqgr$22.6 Bil
PHG
Koninklijke Philips NV ADRLfcgjzxcKwjbjjq$18.2 Bil
PODD
Insulet CorpZrmywfylpKqvknz$11.6 Bil

Sponsor Center